Data-driven stock analysis, valuation deep dives, and financial forensics. Every article backed by the numbers.
At 0.72x PEG with revenue doubling year-on-year to $215.9 billion, Nvidia's forward multiple tells a radically different story from the trailing headline number.
Revenue is compounding, margins are at historic highs, and the ad engine keeps beating estimates. The question is whether $70 billion in annual AI infrastructure spend is an investment or a bill that comes due.
Revenue stalled. Operating income fell 68% from peak. The stock still trades at 1.35 trillion dollars. The math deserves scrutiny.
Both companies generate enormous cash flow, but their strategies have diverged. Exxon is betting on production growth while Chevron prioritises returns. The data reveals a clear winner.
CVX yields 4.3%, trades at 16x earnings, and has raised its dividend for 37 consecutive years. In an energy sector obsessed with growth, Chevron's restraint is its greatest asset.
Since our previous analysis, copper has strengthened further and BHP's production mix shift is accelerating. Here's what's changed.
CRWD trades at 477x trailing earnings with a market cap of $100 billion. The product is best-in-class, but the price assumes a decade of flawless execution in one of the most competitive markets in tech.
Walmart's operating margin expanded from 3.9% to 4.5% while revenue grew to $674 billion. The data tells a story of a retailer transforming into something more valuable.
$191 billion in revenue, a 37% operating margin, and a capital return programme that makes most tech companies look timid. JPMorgan isn't just a bank — it's a capital allocation machine.
PLTR trades at a multiple that makes most analysts uncomfortable. The operating leverage story underneath it is harder to dismiss than the headline PE suggests.
Lilly's revenue surged from $28.3 billion to $45.0 billion in two years on the back of Mounjaro and Zepbound. At 67x trailing earnings, the market is pricing perfection — and it might be right.
BofA just upgraded Vale to Buy. At 6.3x trailing earnings with iron ore production rising, the market's Brazil discount has become an opportunity.
China generates roughly a third of ASML's revenue. A new House bill wants to cut that off. The EUV monopoly is real, but the valuation assumes a growth path that requires the China relationship to survive.
Multiple Wall Street price target cuts this week confirm what the numbers already show — Nike's operating margin has halved in two years, and recovery requires more than a new CEO.
test sub